Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
8(31%)
Results Posted
56%(5 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_4
4
15%
Ph early_phase_1
3
12%
Ph not_applicable
6
23%
Ph phase_1
3
12%
Ph phase_3
1
4%
Ph phase_2
2
8%

Phase Distribution

6

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution19 total trials
Early Phase 1First-in-human
3(15.8%)
Phase 1Safety & dosage
3(15.8%)
Phase 2Efficacy & side effects
2(10.5%)
Phase 3Large-scale testing
1(5.3%)
Phase 4Post-market surveillance
4(21.1%)
N/ANon-phased studies
6(31.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

8

trials recruiting

Total Trials

26

all time

Status Distribution
Active(10)
Completed(9)
Terminated(2)
Other(5)

Detailed Status

Completed9
Recruiting6
unknown5
Not yet recruiting2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
8
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (15.8%)
Phase 13 (15.8%)
Phase 22 (10.5%)
Phase 31 (5.3%)
Phase 44 (21.1%)
N/A6 (31.6%)

Trials by Status

completed935%
terminated14%
not_yet_recruiting28%
recruiting623%
withdrawn14%
unknown519%
active_not_recruiting28%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT05562791Phase 1

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Recruiting
NCT04022915Phase 1

PET Fibrin Imaging of DVT and PE

Terminated
NCT07454096Phase 4

Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study

Not Yet Recruiting
NCT03458520

Pediatric PET/MR Image Registry

Recruiting
NCT02285192Phase 1

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Active Not Recruiting
NCT07280793Early Phase 1

CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma

Not Yet Recruiting
NCT05097274

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.

Recruiting
NCT06171659

FDG PET/MR Imaging of Peripheral Pain Generators

Recruiting
NCT05463913Phase 4

Lung Nodule Detection Using Ultra-long FOV PET/CT

Recruiting
NCT03764124

Observation Study for Prediction of Allograft Survival and Impact of Imaging in Kidney Transplant Recipients.

Recruiting
NCT01916122Early Phase 1

Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status

Completed
NCT03491059Phase 4

Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette Use

Unknown
NCT04867603

Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions

Completed
NCT05263700Not Applicable

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary

Unknown
NCT04922801

Optimising Molecular Radionuclide Therapy

Completed
NCT03585114Phase 2

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

Active Not Recruiting
NCT02609737Not Applicable

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

Completed
NCT03548727Early Phase 1

Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT

Withdrawn
NCT02981368Phase 2

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Completed
NCT04024748

Verification of Imaging System PCD-1000A

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
26